Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
YR-001 by YIRUI Pharmaceutical Technology for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
YR-001 is under clinical development by YIRUI Pharmaceutical Technology and currently in Phase II for Atopic Dermatitis (Atopic Eczema). According...
YR-001 by YIRUI Pharmaceutical Technology for Psoriasis: Likelihood of Approval
YR-001 is under clinical development by YIRUI Pharmaceutical Technology and currently in Phase I for Psoriasis. According to GlobalData, Phase...
YR-001 by YIRUI Pharmaceutical Technology for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
YR-001 is under clinical development by YIRUI Pharmaceutical Technology and currently in Phase I for Atopic Dermatitis (Atopic Eczema). According...
YR-001 by YIRUI Pharmaceutical Technology for Psoriasis: Likelihood of Approval
YR-001 is under clinical development by YIRUI Pharmaceutical Technology and currently in Phase I for Psoriasis. According to GlobalData, Phase...